PET Imaging of Oral Cavity and Oropharyngeal Cancers.

Journal Article (Journal Article;Review)

Fluorine-18 fluorodeoxyglucose PET/computed tomography (18F-FDG PET/CT) plays an important role in the staging, treatment planning, treatment response assessment, detecting recurrent disease, and predicting prognosis in patients with oral cavity and oropharyngeal squamous cell carcinoma. PET/CT has advantage especially in the detection of nodal, distant metastatic disease and second primary malignancy. PET/MR provides superior soft tissue contrast while decreasing radiation exposure, which is advantageous in evaluation of the primary tumor.

Full Text

Duke Authors

Cited Authors

  • Marcus, C; Subramaniam, RM

Published Date

  • April 2022

Published In

Volume / Issue

  • 17 / 2

Start / End Page

  • 223 - 234

PubMed ID

  • 35256303

Electronic International Standard Serial Number (EISSN)

  • 1879-9809

Digital Object Identifier (DOI)

  • 10.1016/j.cpet.2021.12.005


  • eng

Conference Location

  • United States